Duong, Vu H. http://orcid.org/0000-0003-0278-7727
Begna, Kebede H. http://orcid.org/0000-0003-2730-8593
Kashanian, Sarah
Sweet, Kendra http://orcid.org/0000-0001-6248-3317
Wang, Eunice S. http://orcid.org/0000-0002-8644-0968
Caddell, Ryan
Shafer, Danielle A. http://orcid.org/0000-0003-1020-7569
Singh, Zeba N. http://orcid.org/0000-0002-6269-4541
Baer, Maria R. http://orcid.org/0000-0002-9499-1348
Al-Kali, Aref http://orcid.org/0000-0002-0824-3715
Article History
Received: 7 June 2020
Accepted: 9 July 2020
First Online: 17 July 2020
Compliance with ethical standards
:
: KS has been on advisory boards for Takeda, Bristol-Myers Squibb, and Novartis; reports honoraria from Astellas and Stemline; and has received research funding from Incyte. ESW has had an advisory role with Abbvie, Astellas, Daiichi Sankyo, Dava Oncology/Arog, Genentech, Jazz, Kite Pharmaceuticals, Kura Oncology, Macrogenics, Pfizer, PTC Therapeutics, and Stemline and has been a speaker for Stemline and Pfizer. All other authors report no relevant conflicts of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The respective Institutional Review Boards at each study center approved this study. As this was a retrospective study, informed consent could not be obtained from all patients included in the study.
: Not applicable.
: Not applicable.
: Not applicable.